α2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5
about
Acute kidney injury following cardiac surgery: current understanding and future directionsEvidence for the involvement of epigenetics in the progression of renal fibrogenesisEpigenetics in acute kidney injuryPrevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017 : Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine.Post-bypass dexmedetomidine use and postoperative acute kidney injury in patients undergoing cardiac surgery with cardiopulmonary bypassEpigenetic modifiers reduce inflammation and modulate macrophage phenotype during endotoxemia-induced acute lung injury.Activation of α2 adrenoceptor attenuates lipopolysaccharide-induced hepatic injuryA potential adjuvant chemotherapeutics, 18β-glycyrrhetinic acid, inhibits renal tubular epithelial cells apoptosis via enhancing BMP-7 epigenetically through targeting HDAC2.Epigenetic alterations in acute kidney injury.Glomerular haemodynamics, the renal sympathetic nervous system and sepsis-induced acute kidney injury.DNA methylation protects against cisplatin-induced kidney injury by regulating specific genes, including interferon regulatory factor 8.R1 autonomic nervous system in acute kidney injury.Epigenetics of kidney disease.Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the JAK/STAT signaling activation.Suppression of BMP-7 by histone deacetylase 2 promoted apoptosis of renal tubular epithelial cells in acute kidney injury.Dexmedetomidine reduces lipopolysaccharide induced neuroinflammation, sickness behavior, and anhedonia.Therapeutic effects of histone deacetylase inhibitors on kidney disease.Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation.Who or what controls tendon?
P2860
Q26745473-CEC59D84-22F8-4BE6-91D8-D2401A24D8D5Q26827293-4D4AE7F2-CEAC-4B1D-A338-AFF03F18B6ADQ28080924-6BFC41EF-239C-437C-9B44-7C01F84CF396Q33843623-CC33F77A-3E32-4739-9DAF-00B04E19A160Q35018872-305113AE-CAB6-4F76-B54E-D59EEAA20BF2Q35969116-F70B9751-2B19-4CB8-8CE1-05AEF26E4960Q36261528-84FD042B-A906-489A-8705-7CA9641ACE47Q36870776-F0C77C89-F7A4-4541-B9CA-1CD1ACDFEE23Q38134935-82256AD4-08F0-4936-B6E0-3C665C58D7C2Q38195194-9B582758-BB32-45F1-8E7A-258B688160B8Q38697324-4E2C34AE-63BE-468B-8272-1929311D8F5FQ39100259-E16FE87F-3917-490F-88C2-BC527DD5C5FFQ39175636-E4943F64-CEDD-44B1-A818-7FBE43915140Q43106827-024358F2-C0A3-4585-9F24-E6BED0B77F09Q44218680-62AC146B-62A5-49F8-9D78-AB9B2D4B9963Q47557027-24E7D9D3-E43A-4DBA-9BF1-E2D64AB12D85Q48136812-A39BED67-F4AE-4C47-BD2C-02F08387F0BDQ50879597-B48A49D7-8DAE-4B40-A267-334763D76A7EQ51067500-1BCC2C2A-0630-4C5B-9570-DE34EC86F681
P2860
α2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5
description
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2012
@ast
im November 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2012/11/15)
@sk
vědecký článek publikovaný v roce 2012
@cs
wetenschappelijk artikel (gepubliceerd op 2012/11/15)
@nl
наукова стаття, опублікована в листопаді 2012
@uk
مقالة علمية (نشرت في 15-11-2012)
@ar
name
α2-Adrenoceptor agonist dexmed ...... and inhibiting HDAC2 and HDAC5
@ast
α2-Adrenoceptor agonist dexmed ...... and inhibiting HDAC2 and HDAC5
@en
α2-Adrenoceptor agonist dexmed ...... and inhibiting HDAC2 and HDAC5
@nl
type
label
α2-Adrenoceptor agonist dexmed ...... and inhibiting HDAC2 and HDAC5
@ast
α2-Adrenoceptor agonist dexmed ...... and inhibiting HDAC2 and HDAC5
@en
α2-Adrenoceptor agonist dexmed ...... and inhibiting HDAC2 and HDAC5
@nl
prefLabel
α2-Adrenoceptor agonist dexmed ...... and inhibiting HDAC2 and HDAC5
@ast
α2-Adrenoceptor agonist dexmed ...... and inhibiting HDAC2 and HDAC5
@en
α2-Adrenoceptor agonist dexmed ...... and inhibiting HDAC2 and HDAC5
@nl
P2093
P3181
P1476
α2-Adrenoceptor agonist dexmed ...... and inhibiting HDAC2 and HDAC5
@en
P2093
Chien-Feng Li
Ching-Hua Yeh
Chiou-Feng Lin
Chung-Hsi Hsing
Ding-Ping Sun
Tai-Chi Chen
P304
F1443–1453
P3181
P356
10.1152/AJPRENAL.00143.2012
P577
2012-11-15T00:00:00Z